ALFA Filings
Every announcement, straight from the exchange
Every Aurobindo Pharma board meeting date announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
Aurobindo Pharma's board meets 4 November 2026 to consider Q2 and half-year results and a possible interim dividend. Trading window stays closed until 6 November.
Aurobindo Pharma has scheduled a Board Meeting for August 5, 2026, to consider and approve its standalone and consolidated unaudited financial results for the quarter ended June 30, 2026.
Aurobindo Pharma scheduled a board meeting on May 21, 2026, to approve fiscal 2026 financial results. The trading window remains closed until May 23, 2026.